Live from Psychedelic Science - Part II Business

 
 
 
 

The second episode of our three part series, Live from Psychedelic Science, focuses on business.  We interview seven founders and initiative leaders operating across marketing, legal, standards, drug development, insurance, and ESG.  Listeners get the inside scoop from these industry leaders sharing their experience, both personally and professionally, from attending the largest psychedelic conference in modern history.  We also hear about challenges they’ve faced and if changes in the industry are making those issues better or worse.  

Interviewers

Nigam B. Arora, PhD

Neil Ritter, PhD

Interviewees

John Shute, MBA - CEO and co-founder at Puf Creativ (3:39)

Rebecca Lee Whiting, JD - Founder at Epigram Legal (12:49)

David Vaillencourt, MSc - CEO and founder at The GMP Collective (21:56)

Chris Witowski, PhD - CEO and co-founder at Psilera (32:17)

Kimberly Chew, JD - Co-lead of the psychedelics and emerging therapies practice at Husch Blackwell LLP (41:29)

Leslie Nylund, CPCU - Managing Director of TheraCover at Baldwin Risk Partners (49:17)

Marc Ross, JD - Chief Instigator at Needle Partners (57:37)

Credits:

Cover art by Julia Boot. Podcast audio engineering by Joe Leonardo. Intro music by Buddha by Kontekst. Transition music by K. LOUK. Outro music by Bensounds.

 
Previous
Previous

Live from Psychedelic Science - Part III Culture

Next
Next

Live from Psychedelic Science - Part I Research